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Introduction
COVID-19 infection can cause various changes involving all
structures of the central and peripheral nervous system, as
well as neurophysiological abnormalities on the
electroencephalographic (EEG) pathway.
Purpose
Evaluation of EEG results in children who underwent COVID-19 
based on the analysis of retrospective data, in order to assess 
the type of neurophysiological abnormalities.
Material and methods
Retrospective study analyzing 48 EEG results of children who
had COVID-19, aged between 6 months and 5 years. The
presence of the infection was confirmed by molecular RT-PCR
tests. All children showed various neurological symptoms. The
EEG results were described by qualified specialists in the field.
The SPSS program was used for statistical analysis..
Results
EEG - abnormal background activity (97.9% [95% CI: 95.84-
99.96]; p <0.01), slow diffuse (93.8% [95% CI: 90.29-97.31]; p
<0.01); epileptiform discharges (ED) (33.3% [95% CI: 40.1 -
Conclusions
COVID-19 often causes EEG changes with abnormal background
activity and diffuse slow motion along the route. ED are
uncommon, with an increased rate in children with seizures and
a history of epilepsy. Likewise, this infection can cause post-
infectious epilepsy.
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26.5]; p <0.01). ED – common in seizures (62.5% [95% CI: 74.6–
50.4]; p = 0.52) and in those with a history of epilepsy (43.8%
[95% CI: 56.2–31.4]; p = 0.47), compared with those without
such manifestations (37.5%). Some children with ED had
persistent seizures 1-2 weeks after illness (31.3% [95% CI:
42.89-19.71]; p = 0.054), others - more than one month later
(12.5% [95%: 20.77- 4.23]; p = 0.075). Others developed drug-
resistant epilepsy (18.8% [95% CI: 28.56-9.04]; p = 0.08).
